Qiguo Xiao

Dr. Qiguo Xiao


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
WJWeijie Jiang
Weijie Jiang
SHSiqi He
Siqi He
LLLogen Liu
Logen Liu
XMXia Meng
Xia Meng
JLJing Lu
Jing Lu
JZJia Zhang
Jia Zhang
MicroRNAs belong to the family of non-coding RNAs that participate in cell proliferation, cell death and development. The Müller glial cells are the inherent and specific neuroglia cells in the retinal organisation and play significant roles in retinal neuroprotection, organisational maintenance, inflammation and immunity, regeneration, and the occurrence and development of retinal diseases. However, only a few studies report the underlying mechanism of how miRNAs drive the function of Müller glial cells in the development of retinal diseases. This review aims to summarise the roles of miRNAs in retinal Müller glial cell function, including gliogenesis, inflammation and immunity, regeneration, the development of retinal diseases, and retinal development. This review may point out a novel miRNA-based insight into retinal repair and regeneration. MiRNAs in Müller glial cells may be considered a diagnostic and therapeutic target in the process of retinal repair and regeneration.

9 December 2024 in Experimental Eye Research
Verified
Journal Article
Open access
JLJing Lu
Jing Lu
FLFangfang Lu
Fangfang Lu
ZPZhengwu Peng
Zhengwu Peng
ZZZihe Zhang
Zihe Zhang
WJWeijie Jiang
Weijie Jiang
QXQiguo Xiao
Qiguo Xiao
Dry eye disease (DED) is a prevalent ophthalmic disease that affects millions of people worldwide. Iron overload and macrophage inflammation have been implicated in the development of murine DED, though the specific role of macrophages under iron overload conditions remains unclear. This study aimed to establish a novel iron overload-induced mouse model of DED and investigate macrophage involvement. The model was induced via intraperitoneal injection of D-glucoside iron. Results showed that macrophage depletion via clodronate liposomes (CL) significantly mitigated iron deposit, decreased ocular surface inflammation, improved tear production and restored the structure of ocular surface tissues. Furthermore, CL specifically targeted pro-inflammatory M1 macrophages and reduced levels of the inflammatory cytokines IL-1β, IL-6, and TNF-α, effectively alleviating symptoms of DED. In conclusion, this study characterized a novel iron overload-induced DED mouse model and demenstrated that macrophage depletion mitigated the pathological changes in ocular surface and lacrimal gland tissues caused by iron overload, suggesting potential therapeutic strategies for further investigation in the treatment of DED.

1 October 2025 in Current Drug Delivery
Verified
Journal Article
Open access
PDF file
ZZZihe Zhang
Zihe Zhang
SHSiqi He
Siqi He
WJWeijie Jiang
Weijie Jiang
JLJing Lu
Jing Lu
SLSongbin Liu
Songbin Liu
JZJia Zhang
Jia Zhang
Introduction: Exosomes are nanoscale extracellular vesicles that widely participate in intercellular communication. An increasing number of studies have reported on the neuroprotective effects of stem cell-derived exosomes in brain diseases through various delivery methods. However, only a few reports are available on the delivery and uptake of stem cell-derived exosomes in the brains of mice of different ages. Methods: PKH-26-labelled mesenchymal stem cell-derived exosomes were collected, and their uptake was investigated in the brains of mice aged 2 weeks, 2 months, and >6 months, 24 hours after intranasal delivery. Results: No exosomes were distributed in the whole brains of 2-week-old mice after 24 hours of intranasal delivery. However, a small number of exosomes were found in the olfactory bulb, cortex, and hippocampus of 2-month-old mice, with no exosomes observed in the cerebellum. In contrast, a large number of exosomes were ingested in all brain regions, including the olfactory bulb, cortex, hippocampus, and cerebellum, of >6-month-old mice. Conclusion: Exosomes can enter the brains of adult mice through intranasal administration, but there are differences in the uptake rate among mice of different ages. These findings provide a theoretical basis for the future clinical administration of exosomes for treating brain disorders.

1 January 2026 in Stem Cells International
Verified
Journal Article
Open access
JYJiahuan Yi
Jiahuan Yi
FLFangfang Lu
Fangfang Lu
YTYale Tian
Yale Tian
YWYu Wang
Yu Wang
ZZZihe Zhang
Zihe Zhang
QXQiguo Xiao
Qiguo Xiao
Dry eye disease (DED) is a chronic ocular surface disorder triggered by tear film imbalance, in which inflammatory disruption of immune homeostasis constitutes the core pathological mechanism. Mesenchymal stem cell‐derived exosomes (MSC‐Exos) offer promising anti‐inflammatory therapeutic potential through immune modulation, tissue repair, and their inherently low immunogenicity. This review elucidates MSC‐Exos’ molecular regulation of DED inflammation, demonstrating their suppression of the TLR4/NF‐κB signaling axis, the IRAK1/TRAF6/NF‐κB cascade reaction, the STAT3 transcriptional regulatory network, and the NLRP3 inflammasome activation pathway, while revealing a synergistic mechanism through which MSC‐Exos ameliorate the ocular surface inflammatory microenvironment by modulating the Th17/Treg immune balance via the gut–eye axis and facilitating FBXW7‐mediated ubiquitination degradation pathways. Despite this therapeutic potential, clinical translation is hampered by exosomal heterogeneity, difficulties in standardization, and suboptimal delivery efficiency and long‐term efficacy. Future progress will require the integration of nanotechnology and gene editing to enhance therapeutic functionality, ultimately positioning MSC‐Exos as precision biologics for DED.

16 October 2026 in International Ophthalmology
Verified
Journal Article
Open access
PDF file
XDXujie Deng
Xujie Deng
RHRong Huang
Rong Huang
FLFangfang Lu
Fangfang Lu
SXShigang Xia
Shigang Xia
JZJia Zhang
Jia Zhang
ZWZhi Wang
Zhi Wang
Purpose To investigate the factors influencing the surgical residual deviation after Small Incision Lenticule Extraction (SMILE) and its impact on postoperative higher-order aberrations (HOAs). Methods This retrospective study included 77 patients (146 eyes) who underwent SMILE surgery at our Eye and Vision Center from February 2021 to June 2022. Surgical data collected included uncorrected distance visual acuity (UDVA), refraction, spherical equivalent (SE), corneal curvature, central corneal thickness (CCT), axial length (AL), intraoperative actual refractive correction, posterior corneal surface height (PME), total corneal HOAs, spherical aberration (SA), coma aberration (CA), and trefoil aberration. Changes in central corneal thickness were observed preoperatively and at 1 and 3 months postoperatively. The actual lenticular thickness removed during surgery was compared with the predicted lenticular thickness, and statistical analysis was performed using SPSS version 26.0. Results The average deviation of CCT at 1 month postoperative was − 7.11±9.933 µm, and at 3 months postoperative was − 13.37±9.665 µm. The difference between actual and predicted lenticular thickness showed statistical significance (P<0.05). At 1 month and 3 months postoperative, the ratio of eyes with negative deviation to positive deviation was 113:33 and 137:9, respectively. Statistically significant differences were observed in preoperative CCT, with the negative deviation group positively correlating with preoperative refraction, SE, intraoperative actual refractive correction, curvature, CCT, and PME (P<0.05). Conversely, the positive deviation group showed a negative correlation with preoperative curvature, CCT, and PME (P<0.05). At 1 month and 3 months postoperative, HOAs, SA, CA, and trefoil aberration increased compared to preoperative values, with UDVA, SE, HOAs, SA, and CA showing statistically significant differences (P<0.05). In the negative deviation group at 1 month postoperative, deviation values positively correlated with SE (P<0.05). In the negative deviation group at 3 months postoperative, deviation values were positively correlated with HOAs, SA, and CA (P<0.05). No significant correlation was found between deviation values and UDVA, SE, HOAs, SA, CA, or trefoil aberration in the positive deviation group at both 1 and 3 months postoperative. Conclusion There is a difference between the actual lenticular thickness removed during SMILE and the predicted lenticular thickness. Central corneal thickness gradually increases over time postoperatively. The cutting deviation after SMILE is correlated with preoperative refraction, curvature, and PME, and has a certain impact on postoperative HOAs.

3 November 2026 in Experimental Eye Research
Verified
Journal Article
Open access
BGBaiyi Gu
Baiyi Gu
JLJing Lu
Jing Lu
WJWeijie Jiang
Weijie Jiang
SXShigang Xia
Shigang Xia
ZWZhi Wang
Zhi Wang
JZJia Zhang
Jia Zhang